UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000049856
Receipt number R000056779
Scientific Title A study on the difference in the removal rate of insulin and glucagon for each dialyzer in hemodiafiltration.
Date of disclosure of the study information 2022/12/26
Last modified on 2023/06/06 22:44:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on the difference in the removal rate of insulin and glucagon for each dialyzer in hemodiafiltration.

Acronym

A study on the difference in the removal rate of insulin and glucagon for each dialyzer in hemodiafiltration.

Scientific Title

A study on the difference in the removal rate of insulin and glucagon for each dialyzer in hemodiafiltration.

Scientific Title:Acronym

A study on the difference in the removal rate of insulin and glucagon for each dialyzer in hemodiafiltration.

Region

Japan


Condition

Condition

Type 2 diabetes
Chronic kidney disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To measure whether there is no concentration change for each dialyzer in dialysis patients who are suffering from type 2 diabetes and are undergoing hemodiafiltration, and to what extent the adsorption of the dialyzer is affected.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Removal rate calculated from insulin and glucagon levels on the blood-receiving side and blood-receiving side immediately before the end of hemofiltration.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Type 2 diabetes

Interventions/Control_2

Hemodiafiltration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Persons undergoing hemodiafiltration
Persons with type 2 diabetes
Subjects whose blood insulin concentration was 30 micro-IU/ml or higher after the introduction of dialysis therapy
Over 20 years old

Key exclusion criteria

Those who have requested refusal to participate in this study.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Masanori
Middle name
Last name Abe

Organization

Nihon University School of Medicine

Division name

Department of Nephrology, Hypertension,an Endocrinology

Zip code

1738610

Address

30-1, Oyaguchi Kamicho, Itabashi-Ku, Tokyo, Japan

TEL

+81-3-3972-8111

Email

abe.masanori@nihon-u.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Maruyama

Organization

Nihon University School of Medicine

Division name

Department of Nephrology, Hypertension,an Endocrinology

Zip code

1738610

Address

30-1, Oyaguchi Kamicho, Itabashi-Ku, Tokyo, Japan

TEL

+81-3-3972-8111

Homepage URL


Email

maruyama.takashi@nihon-u.ac.jp


Sponsor or person

Institute

Nihon University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Nihon University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nihon University Itabashi Hospital, Clinical Research Judging Committee

Address

30-1, Oyaguchi Kamicho, Itabashi-Ku, Tokyo, Japan

Tel

+81-3-3972-8111

Email

komoda.nozomi@nihon-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2022 Year 09 Month 22 Day

Date of IRB

2022 Year 10 Month 11 Day

Anticipated trial start date

2022 Year 12 Month 26 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2022 Year 12 Month 21 Day

Last modified on

2023 Year 06 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000056779


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name